Vuja De Sciences: Funding, Investors & Team (Oct 2026)
Vuja De Sciences creates treatments for cancer metastasis that aim to stop cancer from spreading and coming back. They use advanced laboratory technologies for testing on metastatic conditions, along with Comparative Oncology to reduce risks in product development and increase the chances of successful clinical trials in human cancer treatment. The strategies they use for maintaining and supporting cancer therapy target the same mechanisms that are effective for primary tumors and large metastatic tumors.
Vuja De Sciences has raised $700k across 1 funding round on record, the most recent an undisclosed round of $700k announced in May 2024.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Vuja De Sciences Company Profile and Key Stats
Latest funding round on record: May 2024.
Vuja De Sciences Funding Rounds
Vuja De Sciences Founders and Leadership Team
No contact details are on record for this team yet.
Vuja De Sciences Funding Compared to Other Biotechnology Startups
Vuja De Sciences' latest round of $700k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vuja De Sciences in Biotechnology and Hoboken
Companies Similar to Vuja De Sciences
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Vuja De Sciences Funding FAQs
What does Vuja De Sciences do?
Vuja De Sciences creates treatments for cancer metastasis that aim to stop cancer from spreading and coming back. They use advanced laboratory technologies for testing on metastatic conditions, along with Comparative Oncology to reduce risks in product development and increase the chances of successful clinical trials in human cancer treatment. The strategies they use for maintaining and supporting cancer therapy target the same mechanisms that are effective for primary tumors and large metastatic tumors.
How much funding has Vuja De Sciences raised?
Vuja De Sciences has raised $700k across 1 round on record. The most recent is an undisclosed round of $700k announced in May 2024.
When did Vuja De Sciences last raise funding?
Vuja De Sciences' most recent funding round on record is an undisclosed round of $700k, announced in May 2024.
Who founded Vuja De Sciences?
FundedIQ lists Robert E Hurst (Founder) at Vuja De Sciences.
Where is Vuja De Sciences headquartered?
Vuja De Sciences is based in Hoboken, New Jersey, United States.
How many employees does Vuja De Sciences have?
Vuja De Sciences is in the 1-10 employee band.
How does Vuja De Sciences' funding compare to other Biotechnology startups?
Vuja De Sciences' latest round of $700k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Vuja De Sciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vuja De Sciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.